Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically distinct, orally active, and highly potent small ...

The large molecule drug substance CDMO market is anticipated to expand at a CAGR of ~9% during the forecast period. Key ...

BioAge is rapidly advancing its internal small molecule APJ agonist program ... is committed to establishing itself as a global pioneer in GPCR innovative biologics discovery. By integrating a ...

Expansion of Intellectual Property for Novel Small Molecule APJ Agonists BioAge is ... itself as a global pioneer in GPCR innovative biologics discovery. By integrating a world-class GPCR science ...

Learn how antibody to payload design is crucial for advancing ADC technology in oncology and beyond with expert insights.

President Trump’s executive order aims to bring down drug prices while optimizing IP protections, and Congress should pass ...

The biologic excipients market has become a vital component of the pharmaceutical and biotechnology industries, playing a crucial role in the formulation of biologic drugs. These excipients are ...

Biologics Contract Manufacturing Market Explore the booming biologics contract manufacturing market, set to reach $83.47B by 2033, driven b ...

The investigational drug demonstrated robust STAT6 degradation in blood and skin that was well tolerated and safe in healthy ...

Patent claims reciting compounds where at least one group of a compound genus is defined by its function are common. For ...

High-quality, high-yield dividend stocks like these five offer a degree of safety and are likely to remain in strong demand.